Interferon beta-1a SubQ injection Treatment Report
Most Popular Brands: Rebif
Generic Name: Interferon beta-1a SubQ injection
What is Interferon beta-1a SubQ injection?
Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my Devic's progress | 4 |
|
2 | ||||
| Other | 2 | 0 |
Mouse over the table for more information
Side Effects
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
1 | 33% |
|
|
Doctor's advice
|
1 | 33% |
|
|
Other
|
1 | 33% |
|
|
Course of treatment ended
|
1 | 33% |
|
See all 3 patients who’ve stopped taking Interferon beta-1a SubQ injection
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.